TRPV6 as A Target for Cancer Therapy

Area of Science:

• Ion channel biology
• Molecular physiology
• Cancer biology

Background:

• Transient Receptor Potential (TRP) channels are a diverse class of ion channels involved in sensing physical and chemical stimuli.
• TRP channels play roles in thermoreception, chemoreception, mechanotransduction, and pain signaling.
• TRPV6, a member of the vanilloid subfamily, is highly selective for calcium and vital for whole-body calcium homeostasis.

Purpose of the Study:

• To review and update recent research on the role of TRPV6 in cancer.
• To highlight TRPV6 as a potential therapeutic drug target in various epithelial cancers.

Main Methods:

• Literature review of published research on TRPV6.
• Analysis of TRPV6 expression and function in cancer contexts.

Main Results:

• TRPV6 expression is significantly elevated in several epithelial cancers, including breast, ovarian, prostate, and pancreatic cancers.
• Dysfunctional calcium control is a hallmark of cancer, and TRPV6 is implicated in this process.
• TRPV6's role in cancer progression and its potential as a drug target are supported by current evidence.

Conclusions:

• TRPV6 is a promising therapeutic target for epithelial cancers due to its role in calcium homeostasis and its elevated expression in malignant tissues.
• Targeting TRPV6 may offer a novel strategy for cancer treatment, particularly in breast, ovarian, prostate, and pancreatic cancers.